3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
12
Neoplasm Metastasis
6
Glioblastoma
4
Triple Negative Breast Neoplasms
3
Brain Neoplasms
3
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Carcinoma, Non-Small-Cell Lung
2
Treatment for Metastatic or Locally Advanced Cervical Cancer
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pre-menopausal Breast Cancer
1
Non-Small Cell Lunch Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Locally Advanced Solid Tumor
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
NVP-BKM120
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pre-menopausal Breast Cancer
×
NVP-BKM120
×
Clear all
NCT02058381
2020-03-09
B-YOND
Novartis
Phase 1
Completed
40 enrolled